Cell-based immunotherapy in gynecologic malignancies.
Curr Opin Obstet Gynecol
; 33(1): 13-18, 2021 02 01.
Article
en En
| MEDLINE
| ID: mdl-33278077
ABSTRACT
PURPOSE OF REVIEW To provide an update on cell-based immunotherapies in solid tumors particularly in gynecological cancers. RECENT FINDINGS:
Recent clinical trial results demonstrate safety and tolerability of different cell therapies in gynecological cancers. Novel approaches, such as harnessing the cells of the innate immune system are also under investigation in a phase I trial.SUMMARY:
Cell-based therapies are gaining widespread attention as evidenced by the increasing number of clinical trials encompassing both, innate and adaptive cells to target gynecological cancers. A majority of these therapeutic approaches are well tolerated and show promising results in early trials.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Tratamiento Basado en Trasplante de Células y Tejidos
/
Neoplasias de los Genitales Femeninos
/
Inmunoterapia
Límite:
Female
/
Humans
Idioma:
En
Revista:
Curr Opin Obstet Gynecol
Asunto de la revista:
GINECOLOGIA
/
OBSTETRICIA
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos